Rankings
▼
Calendar
AUPH (Aurinia Pharmaceuticals Inc.) Stock Financials & Earnings | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇨🇦 Canada
·
NASDAQ
Revenue (TTM)
$283M
Net Income (TTM)
$287M
EPS (TTM)
$2.07
Free Cash Flow (TTM)
$134M
Gross Margin
88.5%
Op. Margin
37.1%
Net Margin
101.5%
FCF Margin
47.5%
P/S Ratio (TTM)
6.9x
P/E Ratio (TTM)
6.8x
YoY Rev Growth
+20.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$34M
$34M
-$30M
Q2 23
$41M
$40M
-$16M
Q3 23
$55M
$48M
-$16M
Q4 23
$45M
$40M
-$30M
Q1 24
$50M
$43M
-$11M
Q2 24
$57M
$48M
-$2M
Q3 24
$68M
$62M
$12M
Q4 24
$60M
$54M
-$2M
Q1 25
$62M
$54M
$22M
Q2 25
$70M
$63M
$20M
Q3 25
$73M
$65M
$30M
Q4 25
$77M
$69M
$33M
marketcaparena.com
Revenue Breakdown
AUPH
Aurinia Pharmaceuticals Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
13.4x
—
Q2 23
12.3x
—
Q3 23
12.4x
—
Q4 23
11.2x
—
Q1 24
10.3x
—
Q2 24
9.5x
—
Q3 24
8.9x
—
Q4 24
8.4x
341.7x
Q1 25
7.9x
49.3x
Q2 25
7.6x
32.4x
Q3 25
7.4x
25.2x
Q4 25
6.9x
6.8x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$32M
-$32M
Q2 23
-$3M
-$3M
Q3 23
-$13M
-$13M
Q4 23
$14M
$14M
Q1 24
-$19M
-$19M
Q2 24
$16M
$16M
Q3 24
$17M
$17M
Q4 24
$30M
$30M
Q1 25
$1M
$1M
Q2 25
$44M
$44M
Q3 25
$44M
$44M
Q4 25
$45M
$45M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$509K
Q2 23
$227K
Q3 23
$105K
Q4 23
$59K
Q1 24
$12K
Q2 24
$128K
Q3 24
$85K
Q4 24
$56K
Q1 25
$17K
Q2 25
$98K
Q3 25
$65K
Q4 25
$70K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+59.1%
+7.5%
Q2 23
+47.2%
-10.2%
Q3 23
-2.3%
+8.4%
Q4 23
+58.6%
+32.3%
Q1 24
+46.2%
-4.7%
Q2 24
+37.8%
+1.8%
Q3 24
+24.3%
-20.8%
Q4 24
+32.8%
-17.7%
Q1 25
+24.2%
-33.4%
Q2 25
+22.4%
-15.0%
Q3 25
+8.4%
-22.0%
Q4 25
+28.8%
-28.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$9M
27.5%
Q2 23
$12M
29.6%
Q3 23
$12M
21.7%
Q4 23
$12M
26.1%
Q1 24
$6M
11.4%
Q2 24
$9M
15.0%
Q3 24
$8M
12.3%
Q4 24
$9M
14.9%
Q1 25
-$3M
-5.5%
Q2 25
$5M
7.8%
Q3 25
$6M
8.1%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$13M
$50M
—
—
Q2 23
$13M
$44M
—
—
Q3 23
$14M
$48M
—
—
Q4 23
$10M
$50M
—
—
Q1 24
$6M
$45M
$3M
—
Q2 24
$4M
$41M
$4M
—
Q3 24
$3M
$40M
—
—
Q4 24
$8M
$31M
$14M
—
Q1 25
$6M
$19M
$970K
—
Q2 25
$7M
$25M
$848K
—
Q3 25
$8M
—
—
$26M
Q4 25
$11M
—
—
$29M
marketcaparena.com
Revenue Segments
License, Royalty and Collaboration Revenue
Product
License, Collaboration and Royalty Revenue
Quarter
License, Royalty and Collaboration Revenue
Product
License, Collaboration and Royalty Revenue
Q1 23
$72K
$34M
—
Q2 23
$394K
$41M
—
Q3 23
$14M
$41M
—
Q1 24
$2M
$48M
—
Q2 24
$2M
$55M
—
Q3 24
$12M
$56M
—
Q4 24
—
$58M
—
Q1 25
—
$60M
$2M
Q2 25
—
$67M
$3M
Q3 25
—
$71M
$3M
Q4 25
—
$74M
$3M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$89M
$273M
$362M
Q2 23
$82M
$269M
$351M
Q3 23
$46M
$292M
$338M
Q4 23
$49M
$302M
$350M
Q1 24
$64M
$255M
$320M
Q2 24
$33M
$297M
$330M
Q3 24
$37M
$312M
$349M
Q4 24
$83M
$275M
$358M
Q1 25
$66M
$246M
$313M
Q2 25
$53M
$262M
$315M
Q3 25
$73M
$279M
$352M
Q4 25
$80M
$318M
$398M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
143M
+0.3%
Q2 23
143M
+0.1%
Q3 23
143M
+0.0%
Q4 23
144M
+0.5%
Q1 24
144M
+0.3%
Q2 24
144M
+0.1%
Q3 24
146M
+1.1%
Q4 24
148M
+1.4%
Q1 25
139M
-5.9%
Q2 25
143M
+3.1%
Q3 25
136M
-5.0%
Q4 25
139M
+2.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
$170K
294
FY 21
$152K
300
FY 22
$447K
300
FY 23
$585K
300
FY 24
$2M
130
FY 25
$1K
200K
marketcaparena.com